Antigen target: Nucleocapsid protein, ʻaʻole i hoʻopilikia ʻia e ka mutation virus
Maikaʻi kumu waiwai: Humanized antibody, kiʻekiʻe kikoʻī
Nā nanoparticles gula mai Kelemānia, Merck (Top 1), kiʻekiʻe sensitivity
ʻO ka pahu hoʻāʻo antigen COVID-19 maikaʻi loa AMPRP78
ʻO ka SARS-CoV-2 Antigen Test Kit AMPRP78 he immunoassay holo lateral wikiwiki e ʻike pono i nā antigens kikoʻī i ka AMPRP78 i loko o ka ʻōpū hanu kanaka, kōkua i ka nānā ʻana a ʻike paha i ka maʻi a i ʻole ka maʻi mua o ka coronavirus novel.
He koho maikaʻi loa o nā mea
1. ʻO ka antigen manaʻo: Nucleocapsid protein, ʻaʻole i hoʻopilikia ʻia e ka mutation virus.
2.Excellent maka mea: Humanized antibody, kiekie specificity.
3.Gold nanoparticles mai German, Merck (Top 1), kiʻekiʻe sensitivity.
4.NC membrane mai German, Sartorius (Top 1), kiʻekiʻe kiʻekiʻe.
5.Sterile swab i hōʻoia ʻia e ka Notified Body.
Lepu COVID-19 antigen test kit AMPRP78 no ke kūʻai aku
1.Multi-specification kits: 1, 5, 10, 25 T / Kit hiki ke hāʻawi.
2.The pre-packaged diluent hiki ke hui pololei me ka swab samples a hoʻohana, ʻaʻole pono e hoʻokaʻawale hou.ʻOi aku ka maikaʻi o ka mea hoʻohana, hiki ke hoʻohana ʻia me ka pūʻulu reagent liʻiliʻi e hoʻopōkole i ke kaʻina hana a hōʻemi i ka pollution i hana ʻia e ke kanaka.
Lepu COVID-19 antigen kit hoʻāʻo AMPRP78 no ke kūʻai ʻana i ka hana lapaʻau hoʻokūkū
1.Positive pākēneka aelike (sensitivity): 95.03% (95%CI: 90.77%~97.70%)
2.Negative pākēneka aelike (specific): 99.02% (95%CI: 96.52-99.88%)
3. Ka nui o ka pakeneka aelike (pololei): 97.15% (95%CI: 94.96%~98.57%)
ʻĀina hoʻopaʻa inoa: Kelemānia, Palani, Italia, Peru, Serbia a me nā mea hou aku.
